• 00D
  • 00H
  • 00M
  • 00S

Sponsors & Exhibitors

Connect with Industry Leaders

2024 Sponsors and Exhibitors

Platinum Sponsor

Gold Sponsors

Silver Sponsors

Catering Sponsor



To discuss sponsorship and exhibition opportunities, please contact

Rebecca Teuma
Sponsorship Sales Manager
T: +61 2 9213 4007
E: Rebecca.teuma@wearemci.com

Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. We are anchored in our commitment to clinician education to support the evolving needs of the urological community. Boston Scientific offers a range of solutions for the treatment of kidney stones, benign prostatic hyperplasia (BPH), erectile dysfunction (ED), male incontinence and pelvic floor disorders.

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.


GenesisCare is an Australian based global company
We have more than 440 centres to help us bring the right care to our patients. For radiotherapy, that includes 14 centres in the UK, 21 in Spain, 36 in Australia and 300 in the U.S. We also offer cardiology and sleep services at more than 80 locations across Australia. Every year our team sees more than 400,000 people globally.

We work to develop detailed understanding of patient needs to design the right care plan whether being treated for cancer, heart disease or sleep disorders.

There are seven GenesisCare radiotherapy centres in the Melbourne Metro region.


Bayer is a global life science company with expertise in healthcare and agriculture. Guided by our purpose, Science For A Better Life, Bayer has been making a positive difference to the lives of Australians since 1925. As people live longer and the population continues to grow, Bayer is one of the few companies that takes a comprehensive view of these issues. We apply our global scientific expertise in healthcare and agriculture to deliver innovations locally to help people and the planet thrive.

Approval number: PP-NUB-AU-0101-1
Date of preparation: August 2021

Mayne Pharma

At Mayne Pharma we are committed to delivering the best health outcomes for Australian patients. We use our unique oral drug delivery systems to improve formulations and in-license novel medicines from around the world to improve access for Australians. Through innovation and collaborative partnerships, we deliver products that address unmet clinical needs. We are proud to support the areas of women’s and men’s health, dermatology, and infectious disease.


Astellas stands on the forefront of healthcare change, turning innovative science into VALUE for patients. Astellas is a global pharmaceutical company headquartered in Japan, with a team of more than 14,500 people in over 70 countries worldwide.*Making a positive impact on patients’ lives is the purpose behind everything we do. We focus our research and development on healthcare solutions that have the greatest potential to transform lives. We are relentless in our pursuit of scientific progress and in tackling unmet medical needs.  Our medicines are extending and enhancing quality of life for those living with conditions that have limited or no alternative treatment options. Our ‘Focus Area’ approach means that we approach drug discovery, research and development from multiple perspectives. At every level of Astellas, we put patients first to advance innovative early science into breakthrough treatments that can directly improve peoples’ lives. In Australia our local team draws on the strength, heritage and expertise of Astellas globally to help improve the health of patients across the country. Our culture of doing good for others and contributing to a sustainable society is underpinned by our core values of patient focus, ownership, results, openness and integrity.


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.

The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit: www.astrazeneca.com


Ipsen provides specialty medicines to Healthcare Professionals and their patients suffering from debilitating diseases.

At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals.

Ipsen is the Australian affiliate of a global R & D focused pharmaceutical company.


Mundipharma is a healthcare company that provides healthcare products to Australians to enable them to live well and age well. We improve patients’ lives in meaningful ways by providing effective therapies along with educational resources that support their proper use. Mundipharma Australia is a member of a global network of independent associated companies which are engaged in research, development, production and marketing of prescription medicines and healthcare products. Our areas of expertise in ethical medicine include pain, oncology, respiratory disease, and ophthalmology.

Device Technologies

For over 25 years, Device Technologies has been pioneering possibility in the Australasian healthcare landscape – seeking out and bringing to market, some of the world’s most advanced healthcare products. From high-quality consumables to advanced theatre equipment and robotics, Device Technologies is Australasia’s largest independent provider of medical solutions and technologies. Partnering with the world’s most innovative medical companies, we offer a comprehensive range of supplies with client care at the core of our values. Our dedicated team of over 750 highly skilled healthcare specialists and support staff, is committed to providing superior outcomes for healthcare professionals and their patients across the entire healthcare community.

Seipel Group

Seipel Group Pty Ltd is an Australian company committed to the research and development of innovative formulations to improve urinary control at all life stages. Products include Urox®, Prorox® and Urox® Junior for the treatment of overactive bladder, male and female incontinence, bedwetting and chronic cystitis.

CIPLA Australia

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.


AbbVie is a global biopharmaceutical company committed to developing innovative therapies for some of the world’s most complex conditions. In Australia we employ more than 450 people with our therapies currently benefiting more than 40,000 Australians across several therapeutic areas: Immunology, Oncology, Virology, Neuroscience and Aesthetics.


Since its beginnings in 1945, KARL STORZ Endoscopy has established itself as the market leader in the manufacturing and sale of endoscopic devices and cameras to hospitals worldwide. 

The KARL STORZ range of products for Urology includes the Flex Xc video ureteroscope for the treatment of stones,  C-View Video Cystoscope with a portable monitor for visualisation of the bladder at the bedside.  

KARL STORZ is also the proud manufacturer of an innovative camera platform known as Image 1s which combines three visualisation technologies: Clara, Chroma and Spectra A/B for diagnosis and treatment of bladder, kidney and ureteral tumours to give you the best endoscopic viewing experience. 

Palette Life Sciences

Palette Life Sciences is transforming applications of existing technologies to provide novel solutions for under-served conditions. 

The company’s portfolio of products in Australia includes Deflux for Vesico Ureteral Reflux (VUR) in children and, BARRIGEL, a bio-compatible injectable treatment for protection of the rectal wall when treating prostate cancer with radiation.  

Lumus Imaging

For many years, Healthcare Imaging Services have operated under multiple brand names across Australia to provide a variety of imaging services to our patients, referrers, suppliers, and partners. As we continue to support our aim to be a customer-centric healthcare business, we have unified all our Health Care Imaging Services brands under one national brand, Lumus Imaging®. Lumus Imaging harnesses all of our knowledge and expertise and combines it with the empathy and care of our people. 

In addition to refreshing our brand identity across our 135 site nationally, Lumus Imaging is updating services, focusing on digital capabilities, and enhancing the way the business interacts with its patients and referrers. No matter where you are or what you need, at Lumus Imaging, we are here to provide you with the knowledge that matters by people that care.